APR 21, 2020 8:05 AM PDT

Scientists develop tumor immunity map

A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecules. The map provides hope for expanding the number of patients who could be receptive to immunotherapy treatments. In developing the map, the research team behind the study analyzed human leukocyte antigens (HLAs) that are not typically included in HLA-based immunotherapies.

HLAs are important because HLA-restricted T cell responses can induce antitumor effects in cancer patients; however, previous studies have typically focused on the few HLA alleles prevalent in a specific subset of ethnic groups. These researchers wanted to expand the knowledge to include a wider population.

"Most studies have focused on HLA proteins that are commonly found in the general population," explains co-first author Kenji Murata, a postdoctoral fellow at the Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. "We have developed a new technique that allows the sampling of underrepresented HLA proteins to find peptides or antigens that can induce an anti-tumor immune response. We can then stimulate the patient's own immune cells with those peptides and give them back to the patient to help treat their cancer."

In their analysis, the team isolated T cells from patients with melanoma with 25 different types of HLAs. This combination let them analyze T cell interactions with more than 800 different antigen peptides. As the authors write in their study, “We were able to determine the specificity, on average, of 12.2% of the tumor-infiltrating T lymphocytes recognizing a mean of 3.1 shared antigen-derived epitopes across HLA-A, B, and C. Furthermore, we isolated a number of cognate T cell receptor genes with tumor reactivity.”

The researchers hope their map will broaden the audience of those cancer patients who are receptive to immunotherapies. "By querying human melanoma-derived T cells and using novel HLA proteins bearing common tumor antigens, we have been able to discover both new and existing immunologically active antigens in tumors," concludes senior author Naoto Hirano, Senior Scientist at the Princess Margaret Cancer Centre. "Our strategy allows for a more complete examination of the immune response and development of novel cancer vaccines and immunotherapies for a broader group of patients not limited by HLA prevalence or tumor mutation burden."

Sources: eLife, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 16, 2020
Immunology
Cancer Vaccine Charges Toward the Clinic
JUL 16, 2020
Cancer Vaccine Charges Toward the Clinic
Kristen Radford, a professor at Australia’s University of Queensland is among a scientific research team developin ...
AUG 04, 2020
Cancer
Commonly used pesticides, approved by EPA, linked to mammary gland tumors
AUG 04, 2020
Commonly used pesticides, approved by EPA, linked to mammary gland tumors
In an analysis of how regulators review pesticides for their potential to cause cancer, researchers at Silent Spring Ins ...
SEP 11, 2020
Cancer
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
SEP 11, 2020
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
Chemotherapy is a life-saving discovery for cancer patients. One of its biggest drawbacks is the toxicity that comes wit ...
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
SEP 15, 2020
Cancer
Soy helps post-op treatment of bone cancer
SEP 15, 2020
Soy helps post-op treatment of bone cancer
New research published in the journal Acta Biomaterialia highlights the post-operative benefits of soy in treatment ...
SEP 16, 2020
Cancer
I'm addicted to the sun, are you?
SEP 16, 2020
I'm addicted to the sun, are you?
New research published in the Journal of Investigative Dermatology reports evidence that some people are geneticall ...
Loading Comments...